SCHEMBL6996599

SCHEMBL6996599

O=C(Nc1ccc2c(c1)C/C(=C/c1ccccc1)C2=O)c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 7/20 0.61
MAOA P21397 5/20 0.61
MAPK14 Q16539 5/20 0.55
MIF P14174 2/20 0.55
ACE2 Q9BYF1 1/20 0.54
NPC1 O15118 2/20 0.53
RAB9A P51151 2/20 0.53
TP53 P04637 1/20 0.53
GAA P10253 1/20 0.53
NFKB1 P19838 1/20 0.53
HTT P42858 1/20 0.53
NFKB2 Q00653 1/20 0.53
RELA Q04206 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
KDM4E B2RXH2 1/20 0.51
LMNA P02545 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
ACHE P22303 1/20 0.50
CASP3 P42574 2/20 0.49
KMT2A Q03164 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6996603 1.00 MAOB (0.61) MAOBMAOAMAPK14MIFACE2
SCHEMBL7703579 0.86 MAOA (0.62) MAOBMAOAMIFNPC1RAB9A
SCHEMBL6997465 0.86 MAOA (0.62) MAOBMAOAMIFNPC1RAB9A
SCHEMBL25970319 0.80 KDM4E (0.74) MAOAMAPK14ACE2NPC1RAB9A
SCHEMBL3363253 0.76 KDM4E (0.82) MAOAMAPK14ACE2NPC1RAB9A
SCHEMBL28667521 0.76 MAOB (1.00) MAOBMAOAMIF
SCHEMBL20809682 0.76 MAOB (0.49) MAOBMAOAMIFNPC1RAB9A
SCHEMBL8744889 0.75 NPC1 (0.71) NPC1RAB9ATP53GAANFKB1
SCHEMBL20809745 0.74 MGLL (0.54) MAOBMAOANPC1RAB9ATP53
SCHEMBL20809517 0.74 MAOB (0.46) MAOBMAOAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1289525-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS Abbott GmbH & Co. KG (DE) 2003-03-12 EP disclosed
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed
WO-2001087846-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS ABBOTT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG & COMPANY KOMMANDITGESELLSCHAFT (DE) 2001-11-22 WO disclosed